Center for Scientific Review; Notice of Closed Meeting, 67748 [2011-28370]
Download as PDF
<![CDATA[
emcdonald on DSK5VPTVN1PROD with NOTICES
67748
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Notices
nominations and other sources as
needed to meet statutory requirements
and to form a balanced committee that
represents the diversity within the
community (details below). Those
eligible for nomination include leaders
or representatives of major autism
spectrum disorder (ASD) research,
advocacy and service organizations,
parents or guardians of individuals with
ASD, individuals on the autism
spectrum, providers, educators,
researchers and other individuals with
professional or personal experience
with ASD. In accordance with White
House Office of Management and
Budget guidelines (FR Doc. 2011–
25736), federally-registered lobbyists are
not eligible. As specified in Public Law
109–416, which has been extended by
Public Law 112–32, the Committee will
carry out the following responsibilities:
(a) Develop a summary of advances in
autism spectrum disorder research
supported or conducted by the Federal
agencies relevant to causes, prevention,
treatment, early screening, diagnosis or
rule out, intervention, and access to
services and supports for individuals
with autism spectrum disorder; (b)
monitor Federal activities with respect
to autism spectrum disorder; (c) make
recommendations to the Secretary
regarding any appropriate changes to
such activities, including
recommendations to the Director of NIH
with respect to the strategic plan; (d)
make recommendations to the Secretary
regarding public participation in
decisions relating to autism spectrum
disorder; (e) develop and annually
update a strategic plan for the conduct
of, and support for, autism spectrum
disorder research, including proposed
budgetary requirements.
In accordance with Public Law 109–
416, which has been extended by Public
Law 112–32, ‘‘Not fewer than 6
members of the Committee, or 1/3 of the
total membership of the Committee,
whichever is greater, shall be composed
of non-Federal public members
appointed by the Secretary, of which—
(a) at least one such member shall be an
individual with a diagnosis of autism
spectrum disorder; (b) at least one such
member shall be a parent or legal
guardian of an individual with an
autism spectrum disorder; and (c) at
least one such member shall be a
representative of leading research,
advocacy, and service organizations for
individuals with autism spectrum
disorder.’’
Public members of the Committee
shall serve for a term of 4 years, and
may be reappointed for one or more
additional 4 year terms. Any member
appointed to fill a vacancy for an
VerDate Mar<15>2010
19:21 Nov 01, 2011
Jkt 226001
unexpired term shall be appointed for
the remainder of such term. A member
may serve after the expiration of the
member’s term until a successor has
taken office. Public members will serve
as Special Government Employees. The
Committee shall meet at the call of the
chairperson or upon the request of the
Secretary. The Committee shall meet not
fewer than 2 times each year.
In 2008–2011, the Committee held an
average of 15 meetings, workshops and
phone conferences per year. Travel
expenses are provided for Committee
members to facilitate attendance at inperson meetings.
The Department strives to ensure that
the membership of HHS Federal
advisory committees is fairly balanced
in terms of points of view represented
and the committee’s function. Every
effort is made to ensure that the views
of women, all ethnic and racial groups,
and people with disabilities are
represented on HHS Federal advisory
committees and, therefore, the
Department encourages nominations of
qualified candidates from these groups.
The Department also encourages
geographic diversity in the composition
of the Committee. Appointment to this
Committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status. Requests for
reasonable accommodation to enable
participation on the Committee should
be indicated in the nomination
submission. Nominations are due by
COB November 30, 2011 and may be
sent to Dr. Susan Daniels, Acting
Director, Office of Autism Research
Coordination/NIMH/NIH, 6001
Executive Boulevard, Room 8185,
Bethesda MD 20892–2190 by standard
or express mail, or via email to
IACCPublicInquiries@mail.nih.gov.
Nominations should include a cover
letter of no longer than 3 pages
describing the candidate’s interest in
seeking appointment to the IACC,
including relevant personal and
professional experience with ASD, as
well as contact information and a
current curriculum vitae or resume.
Please do not include additional
materials unless requested. More
information about the IACC is available
at https://www.iacc.hhs.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: October 27, 2011.
Susan A. Daniels,
Acting Director, Office of Autism Research
Coordination, National Institute of Mental
Health.
National Institutes of Health
[FR Doc. 2011–28375 Filed 11–1–11; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special:
Pilot and Feasibility Clinical Research
Studies in Digestive. Diseases and Nutrition.
Date: November 14, 2011.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road.
Bethesda, MD 20852.
Contact Person: Peter J Perrin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health,6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 27, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–28370 Filed 11–1–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Environmental
Health Sciences; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 76, Number 212 (Wednesday, November 2, 2011)]
[Notices]
[Page 67748]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-28370]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special: Pilot and Feasibility Clinical Research Studies in
Digestive. Diseases and Nutrition.
Date: November 14, 2011.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road. Bethesda, MD 20852.
Contact Person: Peter J Perrin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health,6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD
20892, (301) 435-0682, perrinp@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 27, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-28370 Filed 11-1-11; 8:45 am]
BILLING CODE 4140-01-P
